- NSE
- SUNPHARMA
- BSE
- 524715
- ISIN
- INE044A01036
SUN PHARMACEUTICAL IND L
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹1,904.50
+₹44.50 (+2.39%)
NSE close ·
SUN PHARMACEUTICAL IND L closed at ₹1,904.50 on 9 Nov 2026, up 2.39% on the day, and is up 12.60% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹1,589.30 to ₹2,001.10.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹4,56,953 Cr
- P/E (TTM)
- 41.7
- Industry P/E
- 35.5
- EPS (TTM)
- ₹45.70
- P/B
- 5.12
- Book value
- ₹372.10
- ROE
- 12.3%
- ROCE
- 16.7%
- Debt/equity
- 0.03
- Operating margin
- 21.3%
- Net margin
- 17.8%
- Dividend yield
- 0.84%
Market cap, P/E, P/B and yield at the 9 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +12.17% | +10.51% |
| Net profit | +4.79% | +8.70% |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹16,716 Cr | ₹1,995 Cr | −36.16% | ₹8.30 |
| Jun 2026 | ₹16,024 Cr | ₹2,901 Cr | +26.53% | ₹12.10 |
| Mar 2026 | ₹15,070 Cr | ₹2,710 Cr | +25.80% | ₹11.30 |
| Dec 2025 | ₹16,099 Cr | ₹3,381 Cr | +16.07% | ₹14.00 |
| Sep 2025 | ₹14,948 Cr | ₹3,125 Cr | +2.88% | ₹13.00 |
| Jun 2025 | ₹14,316 Cr | ₹2,293 Cr | −19.84% | ₹9.50 |
| Mar 2025 | ₹13,572 Cr | ₹2,154 Cr | −18.99% | ₹9.00 |
| Dec 2024 | ₹14,141 Cr | ₹2,913 Cr | +13.76% | ₹12.10 |
Armor risk check
SUN PHARMACEUTICAL IND L moves about 1.3× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is SUN PHARMACEUTICAL IND L's share price today?
SUN PHARMACEUTICAL IND L (NSE: SUNPHARMA) closed at ₹1,904.50 on 9 Nov 2026, up 2.39% from the previous close of ₹1,860.00. It traded between ₹1,900.20 and ₹1,943.90 that day.
What are SUN PHARMACEUTICAL IND L's 52-week high and low?
Over the last 52 weeks SUN PHARMACEUTICAL IND L traded between ₹1,583.70 and ₹2,046.90, adjusted for splits and bonuses.
What are SUN PHARMACEUTICAL IND L's NSE symbol, BSE code and ISIN?
SUN PHARMACEUTICAL IND L has NSE symbol SUNPHARMA, BSE code 524715, ISIN INE044A01036.
How has SUN PHARMACEUTICAL IND L performed over 1, 3 and 5 years?
SUN PHARMACEUTICAL IND L's share price return: 1Y +12.60%, 3Y +17.43% a year, 5Y +18.90% a year. Dividends are not included.
Does SUN PHARMACEUTICAL IND L pay a dividend?
Yes. SUN PHARMACEUTICAL IND L's latest dividend went ex on 7 Jul 2026: Final · ₹5.00 per share. Dividends over the past year come to a yield of 0.84% at the latest close.
What is SUN PHARMACEUTICAL IND L's P/E ratio?
SUN PHARMACEUTICAL IND L's P/E ratio is 41.7: the ₹1,904.50 close on 9 Nov 2026 over trailing twelve-month EPS of ₹45.70 (consolidated, four quarters to 30 Sep 2026).
What is SUN PHARMACEUTICAL IND L's market cap?
SUN PHARMACEUTICAL IND L's market cap is ₹4,56,953 Cr at the close on 9 Nov 2026.
Which sector is SUN PHARMACEUTICAL IND L in?
SUN PHARMACEUTICAL IND L is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how SUN PHARMACEUTICAL IND L fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app